European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.
about
Strategies to reduce hepatitis C virus recurrence after liver transplantationManagement of hepatitis c genotype 4 in the liver transplant settingEra of direct acting antivirals in chronic hepatitis C: Who will benefit?Management of Hepatitis C Post-liver Transplantation: a Comprehensive ReviewChallenges of recurrent hepatitis C in the liver transplant patientGenetic Clustering of Hepatitis C Virus Strains and Severity of Recurrent Hepatitis after Liver TransplantationProduction and Characterization of Monoclonal Antibodies Specific for a Conserved Epitope within Hepatitis C Virus Hypervariable Region 1Chronic viral hepatitis C: management updateUpdate on chronic viral hepatitisLong term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrenceHuman monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzeesEfficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infectionTreatment options for HCV nonresponders and relapse patients.Recurrent hepatitis C after liver transplantation.Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.Asian perspectives on viral hepatitis: hepatitis C virus infection.Treatment of hepatitis C virus infectionUse of fluoroquinolones in patients with chronic hepatitis C virus-induced liver failureRetransplantation for graft failure in chronic hepatitis C infection: a good use of a scarce resource?Management of recurrent hepatitis C after liver transplantation.Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantationDiagnosis and management of paediatric hepatitis C virus infection.Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.Hepatitis C: magnitude of the problem.Treatment of recurrent hepatitis C.Retransplantation for recurrent hepatitis C.NK cells, innate immunity and hepatitis C infection after liver transplantation.Histology predicts cirrhotic evolution of post transplant hepatitis CAdvancing donor liver age and rapid fibrosis progression following transplantation for hepatitis CWorsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.Efficacy and safety of sofosbuvir-based interferon-free therapies for hepatitis C in liver transplant recipients.Liver transplantation for hepatitis C virus related liver diseaseInitial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis.Recurrence of diseases following orthotopic liver transplantation.Living-donor liver transplantation and hepatitis CRejection under alpha interferon therapy in liver transplant recipients.Therapeutic management of recurrent hepatitis C after liver transplantation.
P2860
Q22305418-521F8F23-9661-4ACB-9B68-2A852F155976Q26749326-384D98B0-F201-4375-94C2-AF466CA15001Q26777506-D0F2B3DA-C2D3-42CA-8C73-5E3AAEBB7FC0Q26781741-94735B84-EDD2-427B-8A4A-DEE5EB80CDB9Q27011871-864913CC-B2AB-4FC8-8252-C5002DD57FC7Q27469882-A08C28BA-11BC-472B-9C6E-B063FD0F0870Q27470002-81C20B4F-3CC3-4E6C-8C36-E25A2EE33A41Q27471844-AD5F7119-4C3F-4153-B9F2-8DAB0D28C5B6Q27477892-D8B5FA90-7169-4530-AB0D-6AB80ED1644BQ27477988-737A5DE4-5FAB-4484-83D2-18FE889378C3Q28483065-53E80135-8178-481C-9FB0-3FF8D5D34015Q33374906-13D1463A-7E3A-466A-85EF-9A662A7130DFQ33712633-546A7C37-0E06-4F55-8F85-D47474A6FDD2Q33916357-AAA15191-8BFD-4CFE-BEBC-A7C9B1E375A3Q33969819-812070AF-82AC-4D66-A100-D4E512DCEFC4Q34093754-A163339F-A4FF-44BA-AD0C-D982C4E69D2BQ34093760-0E10F5D7-A259-4F8F-AB45-A437DDD465B2Q34095721-0622E9BB-B23C-492D-81A0-580C8C7208DCQ34099424-5A1A2109-5FE5-4639-8A6A-2C06A4AC8FE2Q34143885-7BE6755F-F0AC-4847-96F4-57883C35FA73Q34246962-7A8E9F3E-468C-4F7B-BB9B-9C8C6F6679EFQ34266517-7DDCC956-F91B-4502-B8D4-5AC40C368AC0Q34294938-0D4B80C2-3AFA-490C-9E86-F59EE54EE7AAQ34625761-529F2B6E-43B4-47A9-8C7E-4D2CF1CDD4F1Q34669464-8C46C63D-ED2F-4228-AFD4-3594A5250A30Q34684679-BF622324-5DC4-4D76-86D2-AD89203BE848Q34936115-E260352F-BC9B-4A2F-98B6-DC1A917FE251Q34936164-7CB48B0F-36C9-484A-915E-D490A9AD9DF4Q34936182-5D5DD12D-3A92-4F7D-B7E4-5FB123E6D160Q35019869-B97ED63E-7D25-429A-82DE-616644B1B5C0Q35594584-30ABFA14-A331-4D0D-B05A-8F0805C97E9FQ35594900-7B4D9DCC-020B-4BC3-8A0A-602EB493D0ADQ35598407-8CC53F3E-E56C-4027-9BAB-367E41F59544Q36165389-0F922F4F-44B1-4538-8E48-A3D2D611C98CQ36339458-DC0A4F55-B875-49E0-B0BA-76DC89842F80Q36496437-439ECA47-7E5A-4D0B-B843-3A2B2C0C8E9FQ36505790-6419D6AC-BC98-4E82-8BF2-9E733AAFA59BQ36587253-6EF8075D-158D-4836-9E1F-0F8A2FDDEBE3Q36709673-AD387593-5840-468B-B226-A1B093F7E351Q36758660-B607B9CA-D833-45CD-BF32-F8B027EB9181
P2860
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
European collaborative study o ...... ral Hepatitis (EUROHEP) Group.
@en
European collaborative study o ...... rted Action on Viral Hepatitis
@nl
type
label
European collaborative study o ...... ral Hepatitis (EUROHEP) Group.
@en
European collaborative study o ...... rted Action on Viral Hepatitis
@nl
prefLabel
European collaborative study o ...... ral Hepatitis (EUROHEP) Group.
@en
European collaborative study o ...... rted Action on Viral Hepatitis
@nl
P2093
P50
P1433
P1476
European collaborative study o ...... iral Hepatitis (EUROHEP) Group
@en
P2093
A Minello-Franza
D Botta-Fridlund
G J Alexander
J Gugenheim
K Nachbaur
L Barkholt
P304
P356
10.1016/S0016-5085(99)70454-3
P407
P577
1999-09-01T00:00:00Z